Solius is a new technology to help vitamin D deficient Canadian for human health.
Solius has raised $3.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2026.
Solius's investors include Human Longevity, StartUp Health, Lauder Partners.
Solius is headquartered in Bainbridge Island, United States.
Solius is a new technology to help vitamin D deficient Canadian for human health.
Solius is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Solius — Funding & Investors." VCBacked, May 14, 2026, https://www.vcbacked.co/company/solius. Accessed August 15, 2026.
VCBacked. (2026). Solius — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/solius
{{cite web |title=Solius — Funding & Investors |url=https://www.vcbacked.co/company/solius |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated